1-4 of 4
María-Teresa Cibeira
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma

Ester Lozano, Mari-Pau Mena, Glòria Garrabou, Oriol Cardús, Tania Díaz, David F. Moreno, Joan Mañé-Pujol, Aina Oliver-Caldés, Anthony Battram, Natalia Tovar, María-Teresa Cibeira, Luis-Gerardo Rodríguez-Lobato, Joan Bladé, Carlos Fernández de Larrea, Laura Rosiñol
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (17): 3944–3955.
https://doi.org/10.1158/1078-0432.CCR-24-0117
Published: 03 September 2024
View article titled, Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma
Open the PDF for Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma

Ester Lozano, Mari-Pau Mena, Tania Díaz, Beatriz Martin-Antonio, Sheila León, Luis-Gerardo Rodríguez-Lobato, Aina Oliver-Caldés, Maria Teresa Cibeira, Joan Bladé, Aleix Prat, Laura Rosiñol, Carlos Fernández de Larrea
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4688–4698.
https://doi.org/10.1158/1078-0432.CCR-19-3673
Published: 01 September 2020
View article titled, Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
Open the PDF for Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Impact of MiRSNPs on Survival and Progression in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Carlos Fernández de Larrea, Alfons Navarro, Rut Tejero, Natalia Tovar, Tania Díaz, María Teresa Cibeira, Laura Rosiñol, Gerardo Ferrer, Montserrat Rovira, María Rozman, Mariano Monzó, Joan Bladé
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (13): 3697–3704.
https://doi.org/10.1158/1078-0432.CCR-12-0191
Published: 01 July 2012
View article titled, Impact of MiRSNPs on Survival and Progression in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
Open the PDF for Impact of MiRSNPs on Survival and Progression in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation in another window
Journal Articles

Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma

María Victoria Mateos, Maria Teresa Cibeira, Paul G. Richardson, Felipe Prosper, Albert Oriol, Javier de la Rubia, Juan José Lahuerta, Ramón García-Sanz, Sonia Extremera, Sergio Szyldergemajn, Claudia Corrado, Harald Singer, Constantine S. Mitsiades, Kenneth C. Anderson, Joan Bladé, Jesús San Miguel
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (12): 3260–3269.
https://doi.org/10.1158/1078-0432.CCR-10-0469
Published: 14 June 2010
View article titled, Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma
Open the PDF for Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma in another window